Exploiting the defensive sugars of HIV-1 for drug and vaccine design
The sustained effort towards developing an antibody vaccine against HIV/AIDS has provided much of our understanding of viral immunology. It is generally accepted that one of the main barriers to antibody neutralization of HIV is the array of protective structural carbohydrates that covers the antige...
Príomhchruthaitheoirí: | Scanlan, C, Offer, J, Zitzmann, N, Dwek, R |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
Nature Research
2007
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Emerging principles for the therapeutic exploitation of glycosylation.
de réir: Dalziel, M, et al.
Foilsithe / Cruthaithe: (2014) -
Sugar immunogens
de réir: Dwek, R, et al.
Foilsithe / Cruthaithe: (2009) -
Antigenic mimicry of the HIV envelope by AIDS-Associated pathogens
de réir: Dunlop, D, et al.
Foilsithe / Cruthaithe: (2008) -
Antigenic mimicry of the HIV envelope by AIDS-associated pathogens.
de réir: Dunlop, D, et al.
Foilsithe / Cruthaithe: (2008) -
Yeast mannan genetics controls the molecular specificity of anti-carbohydrate antibodies cross-reactive to the HIV envelope
de réir: Dunlop, D, et al.
Foilsithe / Cruthaithe: (2009)